Key result
Administration of the HDAC inhibitor Vorinostat ameliorated memory impairment and partially restored physiological hippocampal gene expression in a mouse model of heart failure.
Why the study?
Cognitive dysfunction is a severe burden in heart failure patients, but the underlying molecular mechanisms linking the two conditions and corresponding therapeutic strategies were unknown.
Does Vorinostat improve memory function and restore hippocampal gene expression in a mouse model of heart failure?
Does Vorinostat improve memory function and restore hippocampal gene expression in a mouse model of heart failure?
Heart failure induces cognitive impairment via epigenetic changes in hippocampal gene expression, which can be ameliorated by the HDAC inhibitor Vorinostat in a mouse model.
Answers are grounded in this paper and cite their sources.
May support HDAC inhibition for heart failure-related cognitive impairment; hypothesis-generating in mice and leaves open human translation.
In current clinical practice care of diseased patients is often restricted to separated disciplines. However, such an organ-centered approach is not always suitable. For example, cognitive dysfunction is a severe burden in heart failure patients. Moreover, these patients have an increased risk for age-associated dementias. The underlying molecular mechanisms are presently unknown and thus corresponding therapeutic strategies to improve cognition in heart failure patients are missing. Using mice as model organisms we show that heart failure leads to specific changes in hippocampal gene-expression, a brain region intimately linked to cognition. These changes reflect increased cellular stress pathways which eventually lead to loss of neuronal euchromatin and reduced expression of a hippocampal gene cluster essential for cognition. Consequently, mice suffering from heart failure exhibit impaired memory function. These pathological changes are ameliorated via the administration of a drug that promotes neuronal euchromatin formation. Our study provides first insight to the molecular processes by which heart failure contributes to neuronal dysfunction and point to novel therapeutic avenues to treat cognitive defects in heart failure patients.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2020) studied Heart failure-induced memory impairment (n=29). Vorinostat vs. Vehicle was evaluated on Spatial reference memory (Barnes Maze escape latency). Administration of the HDAC inhibitor Vorinostat ameliorated memory impairment and partially restored physiological hippocampal gene expression in a mouse model of heart failure.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: